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In the present study, two phyto-compounds phenyl aldehyde (cinnamaldehyde) and propanoid (eugenol) were
selected to explore their modes of action against Candida albicans. Electron microscopy, flow cytometry and
spectroscopic assays were employed to determine the targets of these compounds. Treatment of C. albicans (CA04)
with sub-MICs of cinnamaldehyde (50 μg/mL) and eugenol (200 μg/mL) indicated multiple sites of action including
damages to cell walls, cell membranes, cytoplasmic contents and other membranous structures as observed under
electron microscopy. Concentration and time dependent increase in the release of cytoplasmic contents
accompanied with change in extracellular K+ concentration was recorded. Exposure of Candida cells at 4 × MIC of
cinnaamldehyde and eugenol resulted in 40.21% and 50.90% dead cells, respectively as revealed by flow cytometry
analysis. Treatment of Candida cells by cinnamaldehyde and eugenol at 0.5 × MIC showed 67.41% and 76.23%
reduction in ergosterol biosynthesis, respectively. The binding assays reflected the ability of compounds to bind
with the ergosterol. Our findings have suggested that the membrane damaging effects of phenyl aldehyde and
propanoids class of compounds is attributed to their ability to inhibit ergosterol biosynthesis and simultaneously
binding with ergosterol. Indirect or secondary action of these compounds on cell wall is also expected as revealed
by electron microscopic studies.
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Candida species are opportunistic pathogens that
cause superficial and systemic diseases in immuno-
compromised patients (Richardson 2005). In such per-
sons, infections caused by Candida albicans are very
common producing oral, vaginal and or systemic can-
didiasis (Claderone 2002). Candidaisis is the fourth
leading blood-borne infection with mortality rates as
high as 47% (Pappas et al. 2003) and morbidity rate (30-
50%) occurs with systemic Candida infections in neutro-
penic transplant patients (Tortorano et al. 2006). Due to
the increasing number of immunosuppressed patients at
an unprecedented rate, the management of these fungal
infections would be a definite challenge to mankind.* Correspondence: khanmsa@hotmail.com
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in any medium, provided the original work is pThe antifungal drugs most commonly used against
these diseases include amphotericin B, ketoconazole, flu-
conazole, terbinafine and flucytosine. The amphotericin
B and azoles targets cell membrane directly or indirectly
whereas newly introduced echinocandins target cell wall
synthesis (Groll and Kolve 2004; Tortorano et al. 2006).
Several current treatments interact unfavorably with
other medications, and have resistance problems, a nar-
row spectrum of activity, limited formulation, toxicity,
and also some are fungistatic as opposed to fungicidal
(Groll and Kolve 2004). As the population of immuno-
compromised patients continues to increase, infectious
diseases have become an escalating problem not only in
developing countries, but also in the United States and
Canada (Sattar et al. 1999). Fungal infections pose a
unique problem because both the mammalian host and
invading fungi are eukaryotic, making it difficult to de-
velop specific antifungal agents that target selectively
only the pathogen.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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for novel and effective antifungal agents, justifying the
intense search for new drugs from various sources in-
cluding natural products that are more effective and less
toxic than those already in use. Plant products tradition-
ally being used in ethnomedicine as effective antifungal
agents, are considered to be a part of the preformed
defense system of higher plants (Baby and George 2008;
Bakkali et al. 2008) and therefore, expected to deliver ac-
tive anti-microbial compounds against infectious diseases.
The phyto-compounds obtained from many aromatic
plants are mixtures of various components (terpenes, alde-
hydes, alcohols, acyclic esters, etc.) with different che-
motypes. They have antifungal effects and their specific
anti-Candida activity is well known (Knobloch et al. 1989;
Khan and Ahmad 2012).
Compounds of chemical groups such as phenyl alde-
hyde (cinnamaldehyde; 3-phenylprop-2-enal) and phenyl
propanoids (eugenol; 4-allyl-2-methoxyphenol) are the
major active compounds of cinnamon (Cinnamomum
verum) and clove (Syzyzgium aromaticum) oils, respect-
ively and have shown promising anti-candidal activities
(Mehmood et al. 1999; Khan and Ahmad 2012). Yet, the
information available regarding the modes of action of
these compounds is not sufficient for effective use in
chemotherapy. Therefore, an attempt was made to ex-
plore the target sites of these two compounds towards
Candida cells. The electron microscopic studies, flow
cytometry, 260 nm absorbing material, extracellular K+
leakage and ergosterol biosynthesis and binding assays
were performed. Observations of the study have revealed
that, in a fungal cell, membranous structures and cell
wall are the target sites of these compounds.
Materials and methods
Organisms and media
In this study, a clinical strain Candida albicans (CA04)
isolated from patient of known candidemia attending the
Jawaharlal Nehru Medical College and Hospital, Aligarh
Muslim University, Aligarh was used. Strain was charac-
terized using morphological and physiological methods
such as use of HiCrome Candida agar and Staib’s medium
(Himedia Laboratories, Mumbai, India), Dalmau tech-
nique, ability to form germ tube and biochemical tests
(such as sugar and nitrogen assimilation, urease test and
nitrate reduction test), 18 s rRNA gene sequencing and
identified as C. albicans (Gene bank accession number
KC607902). The strain CA04 is deposited in the Micro-
bial type Culture Collection, India (collection number
is MTCC 11,802). In addition, a wild type strain of
Escherichia coli (EC01) was used in ergosterol binding
assay. Strain EC01 was isolated from hospital waste water
at Jawaharlal Nehru Medical College and Hospital, Aligarh
Muslim University, Aligarh and characterized on the basisof its growth on differential media and standard biochem-
ical tests. Strain CA04 was grown in Sabouraud dextrose
broth (SDB) and EC01 in nutrient broth (NB).
Compounds and drugs
The test compounds included in this study were
obtained from Himedia Laboratories, Mumbai, India
[cinnamaldehyde (minimum assay 98%) and eugenol
(98%)]. The drug powders of amphotericin B and flu-
conazole were purchased from Himedia Laboratories,
and Pfizer Co, Mumbai, India, respectively. Stock solu-
tions of amphotericin B and fluconazole were prepared
in 1% (v/v) DMSO at a concentration of 25 mg/L and
stored at −20°C until used. Compounds were diluted
ten-fold in 1% (v/v) DMSO and used in the assays.
Determination of minimum inhibitory concentration by
broth macrodilution assays
The minimum inhibitory concentration (MIC) of drugs
was determined against the test strain by CLSI reference
method for broth macrodilution M27-A3 (Clinical and
Laboratory Standards Institute 2008) and as modified by
(Colombo et al. 1995) Briefly, overnight grown culture was
adjusted to 0.5 McFarland standards in RPMI 1640
medium with L-glutamine but without bicarbonate and
buffered to pH 7.0 with MOPS. 0.1 mL of two-fold serial
dilutions of test drugs (10 × concentrations) were made in
the test tubes and 0.9 mL of diluted inoculum medium
was added to each tubes and incubated at 37°C for 48 h.
Drug free control was also included. For the azoles such
as fluconazole, itraconazole and ketoconazole, the MIC
was established as the lowest concentration that inhibited
80% of the control growth. For amphotericin B, MIC was
defined as the lowest concentration that inhibited visible
growth. For MIC determination of test compounds, the
method of (Sokovic and van Griensven 2006) was adapted
with some modifications. Compounds were serially diluted
in 1 mL SDB to achieve a range of concentrations from
45 to 800 μg/mL and 10 μL of yeast suspension (0.5
McFarland) was added and incubated at 37°C for 24 h.
MIC was defined as the lowest concentration that
inhibited visible fungal growth while MFC was the con-
centration at which no growth was observed. Each experi-
ment was repeated three times and mean values were
calculated for MICs and MFCs.
Time kill assay
Test strain CA04 was assessed for time dependent kill-
ing by the test compounds and antifungal drugs namely
amphotericin B and fluconazole. Briefly, 2 ×MIC con-
centrations of compounds and drugs were selected for
assay. Twenty milliliters of phosphate buffered saline
(PBS) solution containing desired concentrations of test
agents were inoculated with 1 ml of yeast suspension
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yeast inoculum but no compounds or drugs. Immediately
after inoculation 100 μl was collected from the solutions
for viable count. Furthermore, test and control solutions
were incubated at 37°C for 48 h. Viable counts were
obtained from 10-fold serial dilutions of test and control
solutions at 2, 4, 6, 8, 12, 24, 36, and 48 h by plating 100 μl
of 10-fold dilution onto SDA plates and incubating at 37°C
for 24 h. Each experiment was performed in triplicate and
the mean colony count for each experiment was converted
to values relative to the mean colony count at 0 h to
normalize the data and correct the variation in starting in-
ocula concentrations. The relative viable count was plotted
against time on a log scale.
Cellular toxicity assay
The toxicity of compounds was evaluated by the red blood
cell (RBC) lysis assay as adapted by (Luiz et al. 2005) with
some modifications. The freshly obtained RBCs of sheep
blood were washed with 1 mL of phosphate buffer (PB)
(pH 7.0) and 4 mL was added to 5% (w/v) glucose solution
to obtain 4% RBC suspension. 750 μL of PB containing
the desired concentration of test agents was mixed with
750 μL of RBC suspension in Eppendorf tubes and in-
cubated at 37°C for 2 h. Triton X-100 (0.1% (v/v)) in PB
was used as a positive control whereas 1% DMSO and
PB were used as negative controls. Tubes were cen-
trifuged at 2000 rpm for 10 min and the absorbances of
supernatant were read at 540 nm. Percent haemolysis
was calculated as: [{(A-B)/(C-B)} × 100]. Where A and
B are the absorbance values of supernatant from the
test sample and PB (solvent control) respectively and C
is the absorbance value of supernatant from the sample
after 100% lysis. Each experiment was performed in
triplicate and the mean values were considered for cal-
culation of percent haemolysis.
Determination of effects of compounds on morphology
and ultrastructure of fungal cell
Scanning electron microscopy
For scanning electron microscopy, 100 μL of cell sus-
pension (0.5 McFarland) was inoculated into 10 mL SDB
treated with sub-MICs of cinnamaldehyde (50 μg/mL)
or eugenol (200 μg/mL) and incubated at 37°C for 48 h
at 120 rpm and harvested to obtain cell pellets. Un-
treated control was also run. Furthermore, harvested cell
pellets were placed into vials containing 3% glutaralde-
hyde in 0.05 M phosphate buffer (pH 6.8) at 4°C and
fixed for 48 h and then dehydrated in an ethanol series
(30%, 50%, 70%, and 95%) for 20 min in each alcohol di-
lution and finally with absolute alcohol for 45 min. The
samples were then dried at critical point in liquid Carbon
dioxide and mounted on standard ½ inch Cambridge SEM
stubs and coated with gold-palladium electroplating (60s,1.8 mA, 2.4 kV) in a Polaron SEM coating system sputter
coater. The samples were examined in a LEO435VP SEM
at 15 kV to assess the changes in cell morphology.
Transmission electron microscopy
Structural changes produced by test compounds towards
fungal cell were evaluated using transmission electron
microscopy. Briefly, 10 mL of SDB treated with sub in-
hibitory concentrations of cinnamaldehyde (50 μg/mL)
or eugenol (200 μg/mL) was inoculated with 100 μL of
cell suspension (0.5 McFarland) and incubated at 37°C
for 48 h at 120 rpm. Control sample did not receive
treatment. The obtained cell pellets were fixed with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for
24 h at room temperature. Post fixation was carried out
in 1% osmium tetroxide in cacodylate buffer. Samples
were dehydrated in acetone and embedded in epon.
Ultra thin sections were stained with 12.5% alcoholic
uranyl acetate and viewed under Morgagni 268D trans-
mission electron microscope at 80 kv. Ultrastructure of
treated and untreated cultures was compared to assess
the effects of compounds.
Determination of effects of compounds on fungal
cell wall
Sorbitol protection assay
Sorbitol assay as described by (Frost et al. 1995) was
performed using the broth microdilution procedure.
Briefly, duplicate plates (96 well) containing test samples
were prepared; one containing two-fold dilutions of test
compounds and the other containing test agents plus
0.8 M sorbitol as an osmoprotectant. All the wells were in-
oculated with 100 μL of cell suspension (0.5 McFarland)
plates were incubated at 37°C. The final assay volume was
200 μL. The plates were read at 2 and 7 days. MIC was de-
fined as the lowest concentration that inhibited visible
fungal growth and evaluated after 5 and 10 days of incuba-
tion. Each experiment was repeated three times in tripli-
cates and mean values were calculated for MICs.
Determination of effects of compounds on fungal cell
membrane permeability and integrity
Release of cellular material
Analysis of loss of cellular material absorbing at 260 nm
from Candida cell was performed using the method of
(Bennis et al. 2004) with little modifications. Briefly,
Candida cells were grown in SDB at 37°C for 48 h and
cell suspension (2.5 × 107 CFU/mL) was prepared in
10 mL PB. Furthermore, this suspension was treated
with different concentrations (1 ×, 2 ×, and 4 ×MIC) of
test agents for 1 h or at fixed concentration (4 ×MIC)
for different time intervals (30, 60, 90 and 120 min). Un-
treated sample was run as negative control and sample
treated with amphotericin B was considered as positive
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10,000 rpm for 10 min, and the absorbances of super-
natant were read at 260 nm using UV–vis spectropho-
tometer (UV5704SS, India).
Extracellular leakage of potassium
Estimation of extracellular K+ leakage from the fungal
cell was performed using the method of (Watanabe et al.
2006) with little modifications. Briefly, Candida cells
were grown in 100 mL SDB at 30°C, 120 rpm for 24 h.
Cell pellets were harvested at 5000 rpm for 5 min and
washed three times with sterile PB and suspended in
10 mL of PB. 500 μL of the cell suspension was used to
determine dry cell weight. 2 mL of cell suspension was
mixed with 2 mL of PB containing desired concentration
(1 ×, 2 × and 4 ×MIC) of test agents and incubated for
4 hr or at a fixed concentration (4 ×MIC) for different
time intervals (30, 60, 120 and 240 min). Amphotericin
B treated cells were used as positive control, whereas
untreated cells as negative control. After treatment sam-
ples were centrifuged at 10,000 rpm for 10 min, and
supernatant was removed and stored for the determin-
ation of extracellular K+ content released into the
medium. The K+ concentration was estimated by Flame
Photometer (Evans Electroselenium LTD, Halsted Essex,
England) using potassium filter.
Flow cytometry analysis for determination of
membrane damage
Flow cytometry analysis was performed to determine
the membrane lesion produced by compounds. The
method of (Pinto et al. 2006) was adapted with some
modifications. Briefly, Candida cells (1.0 × 106 CFU/
mL) were grown in SDB at 35°C up to mid exponential
phase (8 h). The cell suspension was then treated with
1 ×MIC, 2 ×MIC and 4 ×MIC of test agents for 1 h at
35°C. Untreated sample was run as negative control
and sample treated with amphotericin B was con-
sidered as positive control. The suspensions were cen-
trifuged at 5000 rpm, 5 min and washed three times
and re-suspended in PB. The PB suspension was
stained with PI (1 μg/mL) at 35°C in dark for 30 min.
Unstained cells were always included as auto fluo-
rescence controls. Dead cell associated fluorescence
was measured using a FACS Calibur flow cytometer
(Beckman Coulter, MOF10, USA) using a blue argon
laser at 488 nm. The results were analysed using Sumit
4.3 V software. Flouresence in the FL2 channel (Log red
fluorescence, Long pass 630-nm filter) for PI were
acquired and recorded, using a logarithmic scale, for
10,000 events per sample. Scattergram analysis was
performed to evaluate morphological alterations (size
and complexity). For data analysis, quadrants were ad-
justed in raw data density plots of the fluorescenceintensity of control samples in order to include a max-
imum of 5% of the cells in the upper-right quadrant of
plots and then used in the analysis of the remaining
samples to quantify the percentage of stained cells in
the upper-left quadrant in comparison to agent free
controls.
Ergosterol quantitation assay
The method of Arthington-Skaggs et al. (1999) with
slight modifications was used to determine the effect
of test compounds on ergosterol biosynthesis in Can-
dida cells. The total intracellular ergosterol amount
was quantified in Candida cells grown the presence
and absence of test compounds. Briefly, 200 μL of Can-
dida cells (0.5 McFarland) were inoculated into 20 mL
of SDB with and without 1 × MIC, 0.5 × MIC and
0.25 × MIC of test agents and incubated at 35°C for
48 h at 120 rpm. Fluconazole was used as a control.
Cells were harvested by centrifugation at 5000 rpm,
5 min and washed once with distill water, dried at
room temperature and weight of cell pellet was de-
termined. Further, 3 mL of 25% alc. KOH was added to
each pellet and vortexed for 1 min. Suspension was
transferred to borosilicate glass tubes and incubated at
90°C for 1 h in water bath and allowed to cool at room
temperature. Sterol was extracted by addition of 1 mL
of distill water and 3 mL of n-Heptane. Mixture was
vortexed vigorously for 3 min and allowed to stand for
30 min. The heptane layer was transferred to clear
glass tubes and stored at −20°C for 24 h. Prior to
analysis 1 mL of sterol aliquot was diluted 5 fold in
100% ethanol and scanned between 230 to 300 nm
using uv-visible spectrophotometer (UV5704SS, India).
The presence of ergosterol and the late sterol inter-
mediate 24(2*) DHE in the extracted sample resulted
in a characteristic four peaked curve. The absence of
detectable ergosterol content in extract was indicated
by a flat line. The ergosterol content was calculated as
a percentage of the wet weight of the cell by the follo-
wing equations:
% ergosterol þ % 24 28ð Þ DHE ¼ A281:5=290f g  F½ 
=pelletweight
% 24 28ð Þ DHE ¼ A230=518f g  F½ =pelletweight
% ergosterol ¼ % ergosterol þ % 24 28ð Þ DHE½ 
− % 24 28ð Þ DHE
Where, F is the factor for dilution in ethanol and 290
and 518 are the E values (in percentages per centimeter)
determined for crystalline ergosterol and 24(28) DHE,
respectively.
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MIC value determination in the presence of ergosterol
To assess the ability of test compounds to bind membrane
ergosterol in Candida cells, the method as described by
(Escalante et al. 2008) was adapted. The MICs of test com-
pounds were determined in the presence and absence of
external ergosterol in the growth medium. Briefly, tripli-
cate plates containing test samples were prepared; one
containing two-fold dilutions of compounds and the
others containing compounds plus ergosterol at a con-
centration of 100 μg/mL and 200 μg/mL. All the wells
were inoculated with 100 μL of yeast suspension (0.5
McFarland) and plates were incubated at 37°C. The final
assay volume was 200 μL. The plates were read after 48 h
and MIC was determined as the lowest concentration of
test agents inhibiting the visible growth.
Binding assay using centrifugation of intact cells
Candida cells were grown to the mid logarithmic phase in
100 mL of SDB. As a negative control wild type E. coli
strain (EC01) was used and cells were grown to the mid
logarithmic phase in 100 mL of nutrient broth. The cells
were harvested by centrifugation at room temperature at
3000 rpm for 10 min. The pellets were washed twice with
PB and re-suspended in small volume of buffer. A series
of 1 mL cell suspensions ranging from an A600 of 0 to 4
were prepared. The cells were centrifuged at 3000 rpm for
5 min and re-suspended in the same buffer containing
50 μg/mL of test compounds. As a control, cells were re-
suspended in buffer containing no test agents. The cells
were incubated for 1 hr, 900 rpm, at room temperature.
The amount of unbound compounds in supernatant was
determined by measuring absorption at 350 nm.
Fluorescence measurements of unbound filipin
To evaluate the unbound filipin in competition to binding
of membrane ergosterol by eugenol and cinnamaldehyde,
the Candida cells (0.5 McFarland) were incubated for
different time intervals (1, 2, 3 and 4 hrs) in PBS
containing 50 μg/mL of cinnamaldehyde/eugenol.
Amphotericin B treated cells were used as positive
control, whereas untreated cells as negative control.
After incubation cells were harvested by centrifugation
3000 rpm for 5 min. The pellets were washed twice with
PB and re-suspended in small volume of buffer containing
50 μg/mL Filipin III (Sigma, New Delhi). Filipin is a poly-
ene antibiotic frequently used as a probe for its ability to
bind with the membrane ergosterol. After incubation of
cells for 1 hr, 900 rpm, in dark at room temperature, the
amount of unbound filipin in supernatant was determined
by measuring relative fluorescence intensity (excitation at
340 nm and emission at 480 nm) using Synergy H1 Hy-
brid Reader, BioTek. The reduction in binding of filipin to
membrane ergosterol was corresponded to unboundfilipin remained in the supernatant when cells were
pre-treated with cinnamaldehyde/eugenol compared to
untreated cells.
Statistical analysis
All the experiments were performed three times with
three replicates per experiment and data are expressed
as mean ± standard deviation. Statistical significance of
the differences was determined by the one way ANOVA
test using Minitab (V.11.0 for Windows). For cellular
mater release experiment, reduction in OD260 in the
presence of compound was compared to untreated con-
trol by one way ANOVA using Duncan’s method. Simi-
larly, extracellular K+ leakage in terms of m moles/mg
dry weight of cell in treated samples was compared to
untreated control. The unbound amount of filipin in
supernatant was measured in terms of relative fluores-
cent intensity of treated samples compared to un-
treated control. P-values of ≤0.05 were considered as
statistically significant.
Results
MIC of test compounds
MICs of amphotericin B, cinnamaldehyde, fluconazole
and eugenol against the test strain were found to be 1.0,
100, 256 and 400 μg/mL respectively.
Time dependent killing of Candida cells
The time dependent killing of CA04 by the compounds
revealed a decrease of >1log10 in the viable count com-
pared to the control at 8 h by cinnamaldehyde and eu-
genol. Amphotericin B showed a similar effect by 34 h
and fluconazole could not up to 48 h (Figure 1).
Toxicities of compounds to sheep erythrocytes
Test compounds showed no haemolysis at their respect-
ive MFCs to test fungi. Only at a concentration two to
four times higher of MFCs (2304 μg/mL) was partial
haemolysis (10-25%) observed. Similar haemolysis was
observed for amphotericin B even at lower concentra-
tions raging from 0.5 to 2.0 μg/mL. Complete haemoly-
sis was shown by 0.1% (v/v) Triton X-100 as a positive
control and no haemolysis was exhibited by 1% DMSO
and PBS as solvent controls (Table 1).
Effects of compounds on cellular morphology using
scanning electron microscopy
The electron micrographs for CA04 obtained from scan-
ning microscopy observations showed important morpho-
logical damages (Figure 2). Untreated cells appeared to be
oval in shape and with smooth cell surface and polar bud
scars (Figure 2a,b). Cells treated with cinnamaldehyde at
50 μg/mL revealed deformed and interconnected cells
with shrinkage of cell surface, non polar bud scars and
Time (hr)























Figure 1 Time kill assay for eugenol, cinnamaldehyde and antifungal drugs against CA04.
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ment with eugenol at 200 μg/mL resulted in deformed
cells with convoluted and irregular surfaces. Autolysis of
cell and receding of cytoplasmic content from cell mem-
brane was also observed (Figure 2f-i).
Effects of compounds on ultrastructure of fungal cell
using transmission electron microscopy
In untreated sample of Candida cells, organelles such as
nuclei, mitochondria and nucleus are appeared to be
normal (Figure 3a). Treated sample exhibited several
changes including thickening of cell wall, stretching of
cell membrane, expansion of endoplasmic reticulum,
leakage of cell wall and cell membrane, and abnormal
distribution of polysaccharides leading to deterioration
of cytoplasmic contents (Figure 3b-l).
Effects of compounds on fungal cell wall integrity
Cell wall damaging effects of an antimicrobial compound





18 36 72 144
Eugenol 1.65 ± 0.14 1.98 ± 0.09 3.02 ± 0.08 3.72 ±
Cinnamaldehyde 1.84 ± 0.19 2.87 ± 0.07 3.39 ± 0.12 3.96 ±
Antifungal drug Concen
0.125 0.25 0.5 1.0
Amphotericin B 3.56 ± 1.11 8.64 ± 1.89 17.54 ± 2.67 22.45
All the experiments were performed in triplicate and data is presented as mean ± Scompound such as sorbitol. Subsequently MIC of antimicro-
bial is increased several fold in the test medium containing
such compounds. Therefore, to determine the effect of
these agents on fungal cell wall, MIC of cinnamaldehyde,
eugenol and fluconazole (negative control) and congo red
(positive control) was evaluated against CA04 in the pres-
ence and absence of sorbitol. As presented in Table 2,
MIC of eugenol and cinnamaldehyde was increased up to
two-fold against CA04 up to 7 days. Whereas, in the pres-
ence of positive control congo red and negative control
fluconazole, the MICs were increased up to 512- and two-
fold respectively.
Effects of compounds on cell permeability
Effect on cell permeability in terms of cell leakage can
be assessed by measuring intracellular component re-
lease to the medium from washed cells in buffer. Cellu-
lar component which absorb light at 260 nm represent
one class of leakage components, primarily nucleotides
of which uracil containing compounds exhibit strongestd fluconazole
emolysis of RBC (Mean ± SD)
ions of compounds (μg/mL)
288 576 1152 2304
0.16 4.26 ± 0.16 4.78 ± 0.25 5.60 ± 0.63 19.03 ± 0.30
0.05 4.40 ± 0.17 5.06 ± 0.20 6.22 ± 0.19 18.11 ± 0.40
trations of drug (μg/mL)
2.0 4.0 8.0 16.0
± 2.34 31.89 ± 3.22 39.39 ± 3.89 46.11 ± 2.23 58.11 ± 3.10
D.
(a)                                     (b)                               (c)
(d)                                      (e)                                      (f)









Figure 2 Scanning electron micrograph of Candida cells treated with cinnamaldehyde (50 μg/mL) and eugenol (200 μg/mL). (a) untreated;
oval shaped and smooth cell surfaces (b) untreated; arrow indicates polar bud scar. (c-e) treated with cinnamaldehyde; (c) shrinkage of cell membrane
(i) scar on cell surface indicating lysis of cell membrane (ii) lysed and empty cells (iii) (d) deformed interconnected cells (i) with several bud scars
without preferential position at the polar ends (arrows) (ii) deposits of lytic material is seen in the form of vesicles (V) (e) interconnected cells with
convoluted surfaces, loosened cell membrane and receding of cytoplasmic material (i) lysed bud (ii). (f-i) treated with eugenol; (f) deformed cells with
convoluted and irregular surfaces (i) (g) arrows indicate interconnected cells, lysed cell (i) (h) arrow indicates autolysis of cell (i) arrow indicates
receding of cytoplasmic content from cell membrane and disintegration of cellular content.
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environment is also an indicator of interference with
membrane lipid fluidity or integrity. Therefore, to ascer-
tain the effect of these oils onto the cell membrane, the
260 nm absorbing material and K+ leakage was deter-
mined. Further, these membrane damaging effects were
confirmed by flow cytometry.
Membrane damage in terms of extracellular K+ leakage
At 1 ×MIC eugenol induced maximum leakage from the
Candida cells (13.64 m moles/mg dry weight of cell)
followed by amphotericin B and cinnamaldehyde. A fur-
ther increase in K+ leakage with increasing concentration
for each agent was observed (Figure 4a). Values obtained
were statistically significant at P ≤0.05. As evident from
Figure 4b, the time dependent increase in K+ leakage was
observed for test agents at 4 ×MIC compared to untreated
control with the maximum leakage shown by eugenol
(13.90 m moles/mg dry weight of cell).Release of cellular material
Figure 5a shows increase in the release of cellular content
from cells of CA04 in the presence of increasing concen-
tration of test compounds. At 4 ×MIC eugenol was most
effective (P ≤0.05) by exhibiting OD260 of 0.470 followed
by cinnamaldehyde and amphotericin B (OD260 in the
range of 0.403-0.429). The treatment with 4 ×MIC of test
agents induced consistent leakage of intracellular content
with the increase in time. Both the compounds and
amphotericin B showed significant (P ≤0.05) release of cel-
lular material (OD value in the range of 0.450-0.522 at
120 min) compared to untreated control (Figure 5b).
Membrane integrity assay by flow cytometry
Propidium iodide is a nucleic acid biding fluorescent
probe commonly employed to evaluate the effect of
drugs on cell membranes. Cells with sever membrane le-
sion leading to inherent loss of viability will internalize
PI, resulting in an increase in red fluorescence. The PI
(a) (b)
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Figure 3 Transmission electron micrograph of Candida cells
treated with cinnamaldehyde (50 μg/mL) and eugenol (200 μg/
mL). (a) untreated; intact cell wall, cell membranes and other
organelles. (b-f) treated with cinnamaldehyde; (b) disorganized
protoplasm with receding of cell membrane (1), thickening of cell
wall (2) (c) excessive vacuolization (v), loosening of cell membrane
(3), disintegration of cell membrane (4) (d) invagination and
disintegration of cell membrane (5), deposition of lipid globules (e)
disintegrated cytoplasm and lysis of cell wall and membrane (7) (f)
cell wall strength is lost and lysis of cellular material (8). (g-l) Treated
with eugenol; (g) thickening of cell wall (9), loosening of cell
membrane (10) (h) undulating cell wall (11) (i) deposition of lipid
globules (12), disintegration of cell membrane (13) (j) excessive
vacuolization (v), loosening of cell wall and cell membrane (14) (k)
movement of cytoplasmic material to interconnected cell (15) (l)
disintegrated cytoplasm, rupturing of cell membrane (16), swelling
of cell wall (17).
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http://www.amb-express.com/content/3/1/54penetration in Candida cells treated with various con-
centrations of test compounds and positive control is
shown in Figure 6. Our results showed eugenol being
most effective in damaging the cell membrane of
Candida cells in treatment of 1 h. At 4 × MIC, 50.98%
cells were nonviable Figure 5b-d. Cinnamaldehyde
and amphotericn B at this concentration resulted in
uptake of PI by 40.21 and 30.42% cells, respectively
(Figure 6e-g and h-j). Substantial morphological
changes were observed on scattergram of cells upon
treatment with test agents. The production of mem-
brane lesion by test agents was increasing with in-
crease in concentration as presented in Figure 7a,b and
the efficacy was at par with the membrane damaging
effects shown by amphotericin B.
Ergosterol quantitation assay
Table 3 has summarized the effect of test compounds on
ergosterol biosynthesis in CA04 compared to positive
control fluconazole. A decrease in ergosterol biosyn-
thesis with the increasing concentration of test agents
was observed. Eugenol and cinnamaldehyde were most
effective in reducing ergosterol biosynthesis exhibitingTable 2 MIC of cinnamaldehyde and eugenol against




2 days 7 days
-sorbitol +sorbitol -sorbitol +sorbitol
Cinnamaldehyde 20 20 40 80
Eugenol 40 40 40 80
Control
Fluconazole 256 256 256 512
Congo red 0.25 16 0.25 128
Concentration
























































Figure 4 Effects of cinnamaldehyde, eugenol and amphotericin B on the extracellular K+ leakage in CA04. (a) concentration dependent
(b) time dependent.
Khan et al. AMB Express 2013, 3:54 Page 9 of 16
http://www.amb-express.com/content/3/1/5459.61% and 58.96% reduction, respectively compared to
untreated control at 0.25 ×MIC. At 1 ×MIC maximum
reduction of 97.07% was recorded for eugenol followed
by cinnamaldehyde > fluconazole.
Ergosterol binding assay
The ergosterol binding assay revealed a two-to four-
fold increase in MIC of test agents against CA04 in the
presence of 100 μg/mL and 200 μg/mL of ergosterol,
respectively (Table 4). This effect was similar to asshown by positive control amphotericin B. Further-
more, the binding of test compounds to yeast cells was
studied by measuring the absorbance of unbound com-
pound in supernatant (Figure 8a,b). In addition to test
strain, an E. coli wild type strains (EC01) was taken as
negative control, because it contains no sterols in the
plasma membrane. The least amount of binding was
observed for this strain, whereas the increasing cell
density of CA04 showed increased binding of both the
test compounds.
Concentration
























Absorbance at 260 nm












Figure 5 Effects of cinnamaldehyde, eugenol and amphotericin B on the release of 260 nm absorbing material in CA04. (a)
concentration dependent (b) time dependent.
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Also, the cells pretreated with eugenol or cinnamaldehyde
were incubated with ergosterol binding polyene anti-
biotic filipin to check binding of ergosterol efficacy of
eugenol and cinnamaldehyde. The unbound amount of
filipin to compound treated cells was determined com-
pared to untreated cells in terms of fluorescent inten-
sity. As shown in Figure 9, the eugenol was found to
be more effective in binding (significant at P ≤0.05) to
membrane ergosterol followed by amphotericin B and
cinnamaldehyde.Discussion
The commonly used antifungal drugs such as polyenes
and azoles are facing problems of host toxicity and
either intrinsic or acquired resistance by Candida spp
(Groll and Kolve 2004). Therefore, there is a need for
alternative agents to combat candiadiasis. Plant products
have long been used in ethnomedicine and have prom-
ised to provide newer and effective antifungal drugs
(Knobloch et al. 1989; Bakkali et al. 2008, Mehmood
et al. 1999). In spite of well known antifungal properties














Figure 6 Membrane lesion produced by test agents in CA04 as
analyzed by flow cytometry. Sequence of density plots are given
with respective to percentages of PI-stained cells in upper left
quadrant. (a) untreated; (b-d) treated with eugenol at (b) 1 × MIC
(c) 2 × MIC (d) 4 × MIC; (e-g) treated with cinnamaldehyde at (e)
1 × MIC (f) 2 × MIC (g) 4 × MIC; (h-j) treated with amphotericin B at
(h) 1 × MIC (i) 2 × MIC (j) 4 × MIC.
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http://www.amb-express.com/content/3/1/54eugenol and cinnamaldehyde, less information is available
on their mode of action against C. albicans. A better un-
derstanding on mode of action of such compounds may
provide new insights in combating candidiasis. The
present study involved a drug-resistant clinical strain
of C. albicans (CA04) which was identified on the basis of
biochemical and molecular characterization. MICs of
amphotericin B, cinnamaldehyde, fluconazole and eugenol
against the test strain were found to be 1.0, 100, 256 and
400 μg/mL, respectively. The test compounds were found
to be cidal in nature and showed no haemolysis at their re-
spective MFCs to test fungi. Therefore, considering these
compounds being fungicidal and non-toxic to mammalian
cells the study was planned to investigate their mode of
action against the drug-resistant strain of C. albicans. In
this study we have used electron microscopy, flow cytome-
try and other assays to explore various sites of action
shown by such compounds against Candida cells.
To explore the possible mechanism of interaction of
compounds with fungal cell wall, membrane and cellular
content, strain CA04 was subjected to scanning electron
microscopic studies after treatment with sub-inhibitory
concentration of cinnamaldehyde (50 μg/mL) and eu-
genol (200 μg/mL). Untreated cells appeared to be oval
in shape and with smooth cell surface and polar bud
scars. The cell envelope of Candida is appeared to be
damaged by the compounds as evident by shrinkage of
cell surfaces, presence of non-polar bud scars, and re-
ceding of cytoplasm leading to lysis of cells. Increase in
buds and bud scars implies that compound affect normal
division process of yeasts resulting in a single cell with
multiple attempt to divide but not resulting in increase
in viable number of cells (Watanabe et al. 2006). The de-
position of vesicles on to the cell surface is an indicative
of broken cells releasing cytoplasmic materials upon
damage of cell wall and therefore, suggests fungicidal na-
ture of compounds towards yeast cells. Similarly, (Bennis
et al. 2004) observed the surface alternation induced by
thymol and eugenol in Saccharomyces cerevisiae. The
surface alterations are most probably due to the change
in cell permeability showing that the first changes are
localized at the plasmamlema and cell wall before any
alteration can be detected in the cell interior (De Nollin
and Borgers 1974). The indentations of the walls in col-
lapsed cells are indicative of permeability changes that
provoke osmotic imbalance.
Figure 7 Histograms showing comparative analysis of viable and non-viable cells in CA04 treated with cinnamaldehyde, eugenol and
amphotericin B. (a) untreated unstained viable cells (red), eugenol at 1 × MIC (dark blue), cinnamaldehyde at 2 × MIC (light green), cinnamaldehyde at 4
× MIC (yellow), eugenol at 4 × MIC (light blue) (b) untreated unstained viable cells (red), amphotericin B at 2 × MIC (yellow) and 4 × MIC (light blue).
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http://www.amb-express.com/content/3/1/54Further, to ascertain whether sites of action of com-
pounds against Candida cell are at cell wall, cell mem-
brane or other intracellular structures, transmission
electron microscopy was performed. TEM observations of
treated Candida cells showed shrinkage of the protoplast,Table 3 Ergosterol content of CA04 cells treated with various
Test compounds
0.25 ×MIC
Cinnamaldehyde 0.0126 ± 0.001 (58.96)
Eugenol 0.0124 ± 0.001 (59.61)
Fluconazole (control) 0.0257 ± 0.002 (16.29)
Data are presented as a percentage of the wet weight of the cell ± SD, followed in
compared with that of untreated control cell.
Value for untreated control cell was 0.0307 ± 0.003, considered as 100% ergosteroldisruption of the cytoplasmic membrane, decomposition
of inner organelles, thickening of cell wall, and, even un-
dulant cell wall was observed. Other damages include
stretching of cell membrane, expansion of endoplasmic
reticulum, leakage of cell wall and cell membrane, andconcentrations of cinnamaldehyde and eugenol
Mean ergosterol content
0.5 ×MIC 1 ×MIC
0.0101 ± 0.001 (67.41) 0.0022 ± 0.0002 (92.84)
0.0073 ± 0.0004 (76.23) 0.0009 ± 0.00006 (97.07)
0.0197 ± 0.001 (35.81) 0.0118 ± 0.001 (61.57)
parentheses by the reduction (%) in the mean cellular ergosterol content
content in an untreated cell.
Table 4 MIC of cinnamaldehyde and eugenol against CA04 in the absence and presence of ergosterol
Test compounds MIC (μg/mL)
-Ergosterol +Ergosterol (100 μg/mL) +Ergosterol (200 μg/mL)
Cinnamaldehyde 100 200 400
Eugenol 400 1600 1600
Amphotericin B (control) 1.0 2.0 4.0
(−) absence of ergosterol.
(+) presence of ergosterol.
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http://www.amb-express.com/content/3/1/54abnormal distribution of polysaccharides leading to deteri-
oration of cytoplasmic contents. An increase in number
and expansion of endoplasmic reticula serves to detoxify
the drugs or pesticides inside the cell (Park et al. 2007)
and indicates a stimulation response of the cell to com-
pounds as evidenced from our findings. Further, accumu-
lation of polysaccharide granules is responsible for the
rupture of plasmalemma structure (Ghahfarokhi et al.
2004). These observations indicate that mode of action of
such compounds are disrupting the overall intracellular
endomembranous system. Therefore, it appears that cellA600 of cells















































Figure 8 Binding efficiency of (a) cinnamaldehyde and (b)
eugenol to varying cell densities (A600) of Candida cells.wall and cell membrane integrity, along with other mem-
branous structures are the target sites of these com-
pounds. These effects may be attributed to lipophilic
properties of these compounds for their ability to pene-
trate the plasma membrane (Knobloch et al. 1989). Also,
alterations in the cytoplasm and cell organelles may be
responsible for the change of cell architecture causing
deterioration of the cell envelope. Increase in cell wall
thickness of Candida cell due to the comparable deposits
in the form of electron dense vesicles and or irregular
shaped membranous materials were observed in our
study. This effect is similar to the fungal cells treated with
inhibitors of ergosterol synthesis such as azoles and
allylamines which are known to damage membrane be-
cause ergosterol is an essential lipid component of the cell
membrane (Nishiyama et al. 2005).
Further additional level of evidence on mode of action
was assessed by sorbitol protection assay for detection of
cell wall as a target site. A distinctive feature of com-
pounds acting on the fungal cell wall is that the antifun-
gal effect can be reversed in a medium containing an
osmotic stabilizer such as sorbitol. Subsequently MIC of
an antimicrobial is increased several fold in the test
medium containing sorbitol. The marginal increase ob-
served in MIC of test compounds was not enough to con-
clude cell wall as the sole target site by these compounds.
Therefore, it may be suggested that primary target of these
compounds would not be the cell wall synthesis or assem-
bly. However, the morphological changes observed under
electron microscopic studies for the compound treated
fungi led to suggest that fungal membrane could be the
primary target of these compounds.
Therefore, further experiments to examine effects of
compounds on the cell membrane integrity such as deter-
mination of extracellular K+ leakage reflecting cell mem-
brane damage and assays for UV absorbing material that
are released after cell death were also performed. Osmotic
stability has been used with C. albicans and other fungi to
study mode of action of several antibiotics. The amount of
K+ leaked out to the external environment is also an indi-
cator of interference with membrane lipid fluidity or integ-
rity. Eugenol was most damaging in their effects followed
by cinnamaldehyde and amphotericin B. The time and
concentration dependent substantial leakage of K+ from
treated cell has indicated that cytoplasmic membrane is
Time (hr)
























Figure 9 Relative fluorescent intensity of unbound filipin in suspensions of Candida cells treated with cinnamaldehyde, eugenol and
amphotericin B.
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http://www.amb-express.com/content/3/1/54targeted by test compounds and its fluidity and permea-
bility is changed leading to leakage of cytoplasmic ma-
terial. Dysregulation of ion homeostasis rapidly mediates
cell death, forming the mechanistic basis by which a grow-
ing number of amphipathic but structurally unrelated
compounds such as terpenoid phenols elicit antifungal
activity (Zhang et al. 2012). Cellular component which
absorb light at 260 nm represent one class of leakage com-
ponents, primarily nucleotides of which uracil containing
compounds exhibit strongest absorbance. Similar to K +
leakage, eugenol was most effective in its action. In our
study, loss of significant amount of 260 nm absorbing ma-
terial suggests that nucleic acids were lost through dam-
aged cytoplasmic membrane and is an indicative of gross
and irreversible damage to the cytoplasmic membrane by
test compounds (Hugo and Longworth 1964).
Effect of eugenol and cinnamaldehyde on to cell per-
meability was clearly evident from data obtained from
K+ leakage assays and in 260 nm absorbing materials.
This effect was at par with positive control ampho-
tericin B, a membrane disruptive-agent known to affect
cell permeability and lethal action against fungal cell.
These observations highlight fungal membranes as the
sites of action of these compounds. The other workers
have also shown the membrane damaging effects of
eugenol and cinnamaldehyde but stating mechanisms of
action other than those reported in our investigation
(Ahmad et al. 2010; Shreaz et al. 2011).
Further confirmation on membrane damages produced
by these compounds was done by performing the flow
cytometry of treated fungal cells using propidium iodide
(PI) as a fluorescent marker. PI is a nucleic acid bidingfluorescent probe commonly employed to evaluate the
effect of drugs on cell membranes. Cells with sever
membrane lesion leading to inherent loss of viability will
internalize PI, resulting in an increase in red fluores-
cence. The results obtained has confirmed eugenol
being most effective in a dose dependent manner in
damaging the cell membrane of Candida cells followed
by cinnamaldehyde and amphotericn B. Permeation to
PI, particularly following short incubation periods as
shown in our study, indicates that the modes of action
of these compounds against Candida cells involve a pri-
mary lesion of the cell membrane with substantial mor-
phological changes leading to cell death.
Since an antifungal agent exhibiting membrane dam-
aging effects could possibly target structural component
of membrane i.e. ergosterol, either by lowering the synthe-
sis of ergosterol or by binding with it to disrupt the mem-
brane integrity. Therefore, additional experiments for
differentiating these kinds of mechanism, ergosterol quan-
titation and ergosterol binding assays were performed for
Candida cells in the presence of test compounds. In our
study it was observed that ergosterol biosynthesis was de-
creased in Candida cells when treated with the increasing
concentration of test agents. Eugenol and cinnamaldehyde
were most effective in reducing ergosterol biosynthesis
compared to fluconazole, a well known inhibitor of ergos-
terol biosynthesis. (Pinto et al. 2009) have also shown
ergosterol lowering effects by eugenol but no report is
available regarding cinnamaldehyde. Our studies have
revealed a dose dependent decrease in the synthesis of
ergosterol content at sub-MICs of cinnamaldehyde and
eugenol, and the effect was far greater than fluconazole.
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originate from the inhibition of ergosterol biosynthesis.
Further, these compounds were tested for their ability
to bind ergosterol. The ergosterol binding assay re-
vealed a sufficient increase in MIC of test agents against
CA04 similar to as shown by positive control ampho-
tericin B. These data have led us to assume that com-
pounds are binding with the ergosterol freely available
in the medium and hereby amount required to affect
the cellular growth has increased.
To further assure that compounds are binding with
the membrane ergosterol, the cells were incubated with
compounds for a definite period of time and amount
of unbound compound in supernatant was detected
spectrophotometricaly. In addition to test strain, an E.
coli wild type strains (EC01) was taken as negative control,
because it contains no sterols in the plasma membrane.
The least amount of binding of compounds with the
membrane ergosterol was observed for this strain,
whereas the increase in cell density of CA04 resulted in
increased binding of both the test compounds with the
ergosterol. The binding of eugenol and cinnamaldehyde
with membrane ergosterol was further confirmed in
comparison to binding of fluorescent polyene antibiotic
filipin. The measurement of unbound filipin in com-
pound treated cells compared to untreated cells has
shown that membrane ergosterol is occupied signifi-
cantly by eugenol and cinnamaldehyde and therefore in-
crease in unbound amount of filipin in the supernatant
is observed. In our knowledge there is no report on
ergosterol binding ability of these compounds. Here, we
have demonstrated that the ergosterol binding ability of
eugenol and cinnamaldehyde is an added antimicrobial
mode of action from these compounds.
Ergosterol is an important target because it maintains
membrane fluidity, asymmetry and integrity and there-
fore various cell functions (Rodriguez et al. 1985). The
compounds, targeting ergosterol that is unique to fungi
only, would be selectively toxic to fungi and not to the
host cell. Also, the toxicity assay has shown that these
compounds are non-toxic to mammalian cells even at
higher doses. Ergosterol also contributes to proper func-
tioning of membrane bound enzymes (Lupetti et al.
2002). These compounds primarily exert membrane
damaging effects that may be attributed to their ability
to lower the ergosterol biosynthesis and simultaneously
interacting with membrane by binding to ergosterol.
Our findings have highlighted membrane disruption by
these compounds and since cell wall synthesizing en-
zymes are localized in cell membrane, the functioning of
these enzymes is also affected. Therefore, partial or sec-
ondary action of these compounds is supposed to be cell
walls as observed under electron microscopic studies. Not
only cell membranes and cell walls but also the otherendomembranous structures of cytoplasm are targeted
and disrupted by these compounds as evidenced by elec-
tron microscopic studies. It would be difficult for a micro-
organism to overcome these multiple sites of action
shown by an antimicrobial agent and hence to develop
resistance. Therefore, considering the problem of host tox-
icity and drug-resistance and realizing the importance and
need of alternative agents, our findings suggest that phenyl
aldehyde and propanoids class of compounds could be of
great value in developing newer drugs.
In the light of the present findings, it could be pro-
posed that antifungal action of such compounds against
C. albicans, takes place via two step process. The first
step involves the passive entry of compounds being
ampiphillic in nature into plasma membrane in order to
initiate membrane disruption by altering fluidity and in-
tegrity because of reduction in the ergosterol synthesis.
The second stage is the binding of compounds with the
ergosterol and accumulation in the plasma membrane
resulting in the inhibition of cell growth due to in-
creased bilayer disorder, leakage of ions and cytoplasmic
materials resulting in disorganized cytoplasm. These ef-
fects disturb the osmotic balance of cell leading to mem-
brane associated proteins inefficient to perform cellular
functions and eventually leading to cell death.
In conclusion, the present results indicate that phenyl
aldehyde and propanoids classes of compounds acts by
targeting multiple sites in a Candida cell including
damages to the cell membranes and cell walls. Such
effects are attributed to the ability of these compounds
to lower the biosynthesis of ergosterol and also to bind
it on the membrane. Operation of these two modes of
action altogether by such compounds leads to multiple
sites of action in Candida cells and it could be very use-
ful in combating infections caused by drug-resistant
strains. It is suggested that other structurally related
compounds from these classes of plant products should
be screened to obtain novel and effective antifungal
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